COMMUNIQUÉS West-GlobeNewswire

Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
01/11/2018
ENGLEWOOD, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that it will report financial results for the [...]
Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs
01/11/2018
Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading innovator of tests for colorectal cancer, and [...]
111, Inc. to Announce Third Quarter 2018 Financial Results on November 8, 2018
01/11/2018
SHANGHAI, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited [...]
LIDDS presence at BIO-Europe 2018 to focus on NanoZolid's broad drug formulation capability
01/11/2018
At BIO-Europe 2018, LIDDS will be meeting potential licensing and collaborative partners, to discuss the recently announced pre-clinical studies with NanoZolid-technology. The STING study is yet another proof point of [...]
Director/PDMR Shareholding
01/11/2018
DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]
Novan Publication Supports Women’s Health Business Unit Initiative and Nitric Oxide’s Potential Against HPV-Associated Diseases
01/11/2018
Data from SB206 Phase 2 clinical trial in external genital warts have been published in the Journal of Drugs in Dermatology SB206 was efficacious and well tolerated in the trial Advancement of the late stage clinical [...]
Evolus to Participate in Two Upcoming Investor Conferences
01/11/2018
IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced today that members of management will be participating in two upcoming investor [...]
Intra-Cellular Therapies to Host Third Quarter 2018 Financial Results Conference Call and Webcast
01/11/2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced [...]
Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8
01/11/2018
EMERYVILLE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]
Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018
01/11/2018
AUSTIN, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced it will release its third quarter 2018 financial results on Wednesday, November 7, 2018. [...]
3rd Quarter Results
01/11/2018
Shire Delivers Product Sales Growth of 6% and Continues to Execute Against Key Priorities in Q3 2018 Delivered product sales of $3.8 billion; growth driven by Immunology, recently-launched products, and international [...]
Progenics Pharmaceuticals Sets Third Quarter 2018 Financial Results and Business Update Call for November 8
01/11/2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, announced [...]
Kiniksa Reports Third Quarter 2018 Financial Results and Pipeline Progress
01/11/2018
– Rilonacept pivotal Phase 3 clinical trial initiating this year – Mavrilimumab pre-IND meeting complete; plans for global Phase 2 clinical trial advancing – KPL-716 advancing into multiple chronic pruritic diseases, [...]
Genocea Reports Third Quarter 2018 Financial and Operating Results
01/11/2018
Neoantigen vaccine program GEN-009 Phase 1/2a clinical trial enrolling patients Presenting novel findings at upcoming SITC conference Conference call today at 9:00 am ET CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE [...]
Evelo Biosciences Reports Third Quarter 2018 Financial Results and Recent Business Highlights
01/11/2018
-- Approval to Initiate Phase 1b Trial of EDP1815 in Psoriasis and Atopic Dermatitis: Dosing of First Patient Expected in 4Q18 -- -- Initiation of Investigator-Sponsored Phase 2a Trial of EDP1503 in Metastatic Melanoma [...]
Spring Bank Announces Three Poster Presentations on Its Next-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
01/11/2018
HOPKINTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Chimerix to Announce Third Quarter 2018 Financial Results on November 8, 2018
01/11/2018
DURHAM, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a live [...]
Establishment Labs to Release Third Quarter 2018 Financial Results on November 13, 2018
01/11/2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA) today announced that the Company will release its third quarter 2018 financial results on Tuesday, November 13, 2018, prior to [...]
Zafgen to Host Conference Call to Discuss Third Quarter 2018 Financial Results
01/11/2018
BOSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Pages